Physician profile
Amit Chakrabarty
NPI 1598786725
$10,238.89
in general payments reported to CMS, 2019-2025
33 companies · $400 in 2025
The $400 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,904 · 2020: $1,559 · 2021: $2,440 · 2022: $1,053 · 2023: $595 · 2024: $288 · 2025: $400.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,283.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,282.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,493.00 | 2019-2024 | Rezum Generator, Ams 700, Lithovue |
| Cook Incorporated | $991.52 | 2019 | |
| Coloplast Corp | $543.73 | 2020-2022 | |
| Cook Medical LLC | $509.57 | 2019 | |
| Axonics, INC. | $375.82 | 2020-2022 | |
| Caldera Medical, INC | $364.37 | 2019-2022 | |
| Medtronic USA, INC. | $361.48 | 2019-2020 | |
| Healthtronics Stone Solutions, LLC | $305.53 | 2020-2021 | |
| Profound Medical Corp. | $270.86 | 2025 | Tulsa-Pro |
| Medtronic, INC. | $269.60 | 2021-2023 | Interstim |
| Davol INC. | $248.03 | 2022 | |
| Novo Nordisk INC | $228.03 | 2022-2024 | Wegovy |
| Intuitive Surgical, INC. | $145.68 | 2019 | |
| Teleflex LLC | $139.40 | 2021-2022 | |
| Agiliti Surgical, INC. | $129.02 | 2025 | Koelis Trinity Mri/US Fusion, Sonablate Hifu |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $118.87 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $97.67 | 2023 | Gemtesa |
| Tolmar, INC. | $97.29 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $81.59 | 2019-2023 | |
| Srs Medical Systems, INC. | $67.82 | 2020 | |
| Endo Pharmaceuticals INC. | $64.09 | 2019-2022 | |
| 180 Medical, INC. | $56.33 | 2020-2022 | |
| Astellas Pharma US INC | $49.73 | 2019-2023 | Myrbetriq |
| Allergan, INC. | $38.37 | 2020-2021 | |
| Urogen Pharma, INC. | $35.15 | 2023 | Jelmyto |
| Convatec INC. | $34.93 | 2019 | |
| Olympus America INC. | $34.75 | 2023 | Itind System |
| Pfizer INC. | $27.91 | 2019 | |
| Progenics Pharmaceuticals, INC. | $22.30 | 2023 | Pylarify |
| Photocure INC | $13.41 | 2023 | Cysview |
| Dendreon Pharmaceuticals LLC | $12.05 | 2020 | |
| Janssen Biotech, INC. | $10.99 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amit Chakrabarty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.